trailfoam9
About
Combining PD-L1 inhibitors with immunogenic cell death activated through chemo-photothermal treatment with a thermosensitive liposome system to be able to activate tumor-specific immunological response.
Combining PD-L1 inhibitors with immunogenic cell death activated through chemo-photothermal treatment with a thermosensitive liposome system to be able to activate tumor-specific immunological response.